What Anthropic has actually filed

Anthropic, the maker of the Claude models, is widely reported to have filed a confidential draft registration statement, an S-1, with the US Securities and Exchange Commission on 1 June 2026. A confidential filing lets a company begin the listing process without publishing its financials, so the document itself is not public and neither are the figures inside it.

What that means in practice is that the clock on an initial public offering has reportedly started, but the public prospectus that would carry a price range, a share count and a firm date has not appeared. Reporting points to the company holding pre-IPO investor meetings, the step that usually comes before a formal roadshow.

The valuation, and where the number comes from

The figure attached to Anthropic in almost every report is a valuation near 965 billion dollars. That number does not come from a public offering. It comes from its most recent private funding round, which valued the company at roughly 965 billion dollars including the new money. A private-round valuation and an IPO valuation are not the same thing: the first is what a small group of investors agreed to pay, the second is what the public market sets on the day, and the two can differ in either direction.

So the honest reading is that 965 billion dollars is the reported private valuation Anthropic is carrying into the process, not a confirmed IPO price. Anyone quoting it as the price of the shares is quoting the wrong number.

How it compares with OpenAI

Anthropic's move is being read partly as a race with OpenAI, its larger rival. OpenAI has reportedly pushed its own listing to 2027, with its chief executive setting a far higher valuation bar, and its most recent private valuation reported between roughly 730 billion and 852 billion dollars. One reported contrast matters for anyone weighing the two: Anthropic has indicated it expects to reach its first operating profit, while OpenAI is reported to be absorbing heavy losses. We report those as stated positions rather than as verified accounts, because neither company's financials are public.

What is still unknown

Several of the things that actually decide an IPO are simply not on the record yet: the exchange, the ticker, the number of shares, the price range, and the date. Until a public prospectus is filed, any specific listing date or offer price is an expectation rather than a fact. Confidential filings can also be delayed or withdrawn, and companies change their plans as market conditions move.

That uncertainty is the point. A confidential filing is a signal of intent, not a schedule, and the gap between "reportedly filed" and "priced and trading" is where most of the risk sits.

The stages, and where Anthropic sits

An IPO runs through a sequence, and knowing it tells you how far along a company really is. First comes a confidential S-1, filed privately with the regulator, which is the stage Anthropic is reported to be at. Next the company files a public prospectus that sets out its financials, the number of shares and a price range. Then comes the roadshow, where management pitches large investors, followed by pricing the night before trading begins, and finally the listing itself. Anthropic is reported to be near the start of that sequence, with investor meetings under way, which is still several moves away from shares anyone can actually buy.

That is also why dates move. Each of those steps depends on the one before it and on the state of the market, so a company that looks close in the autumn can price in the winter, or wait until the next year, without anything having gone wrong.

How to follow it

We track Anthropic and the other named upcoming listings on our IPO calendar, where each entry carries the source we checked and the date we checked it, and nothing is listed as a forecast. When a public prospectus appears, that is the point at which the real numbers, and a real date, become something you can rely on.